PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.

about

PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.

Item

http://www.wikidata.org/entity/Q40120413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

PARP-1 serves as a novel molec ...... ern Chinese Zhuang population.

@en

type

Item

label

PARP-1 serves as a novel molec ...... ern Chinese Zhuang population.

@en

prefLabel

PARP-1 serves as a novel molec ...... ern Chinese Zhuang population.

@en

P1476

PARP-1 serves as a novel molec ...... ern Chinese Zhuang population.

@en

P2093

Chengdong Zhang

http://www.w3.org/2001/XMLSchema#string

Dongwei Dou

http://www.w3.org/2001/XMLSchema#string

Feifan Xiao

http://www.w3.org/2001/XMLSchema#string

Hongtao Li

http://www.w3.org/2001/XMLSchema#string

Jian Qin

http://www.w3.org/2001/XMLSchema#string

Jiatong Li

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Wenqi Luo

http://www.w3.org/2001/XMLSchema#string

Wenxin Lv

http://www.w3.org/2001/XMLSchema#string

Xiaoli Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma

Functions of PARylation in DNA Damage Repair Pathways

Trial watch - inhibiting PARP enzymes for anticancer therapy

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

PARP inhibition: PARP1 and beyond

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

Risk of HCC: genetic heterogeneity and complex genetics.

High throughput measurement of γH2AX DSB repair kinetics in a healthy human population

Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.

P304

1010428317706914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1010428317706914

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28714367

http://www.w3.org/2001/XMLSchema#string